197 related articles for article (PubMed ID: 36037362)
1. Novel antiinflammatory biologics shaped by parasite-host coevolution.
Ryan SM; Ruscher R; Johnston WA; Pickering DA; Kennedy MW; Smith BO; Jones L; Buitrago G; Field MA; Esterman AJ; McHugh CP; Browne DJ; Cooper MM; Ryan RYM; Doolan DL; Engwerda CR; Miles K; Mitreva M; Croese J; Rahman T; Alexandrov K; Giacomin PR; Loukas A
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2202795119. PubMed ID: 36037362
[TBL] [Abstract][Full Text] [Related]
2. Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis.
Sotillo J; Ferreira I; Potriquet J; Laha T; Navarro S; Loukas A; Mulvenna J
Sci Rep; 2017 Feb; 7():41883. PubMed ID: 28191818
[TBL] [Abstract][Full Text] [Related]
3. Helminth-derived proteins as immune system regulators: a systematic review of their promise in alleviating colitis.
Alghanmi M; Minshawi F; Altorki TA; Zawawi A; Alsaady I; Naser AY; Alwafi H; Alsulami SM; Azhari AA; Hashem AM; Alhabbab R
BMC Immunol; 2024 Apr; 25(1):21. PubMed ID: 38637733
[TBL] [Abstract][Full Text] [Related]
4. Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis.
Ferreira I; Smyth D; Gaze S; Aziz A; Giacomin P; Ruyssers N; Artis D; Laha T; Navarro S; Loukas A; McSorley HJ
Infect Immun; 2013 Jun; 81(6):2104-11. PubMed ID: 23545299
[TBL] [Abstract][Full Text] [Related]
5. Hookworm-Derived Metabolites Suppress Pathology in a Mouse Model of Colitis and Inhibit Secretion of Key Inflammatory Cytokines in Primary Human Leukocytes.
Wangchuk P; Shepherd C; Constantinoiu C; Ryan RYM; Kouremenos KA; Becker L; Jones L; Buitrago G; Giacomin P; Wilson D; Daly N; McConville MJ; Miles JJ; Loukas A
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670556
[TBL] [Abstract][Full Text] [Related]
6. A netrin domain-containing protein secreted by the human hookworm Necator americanus protects against CD4 T cell transfer colitis.
Buitrago G; Pickering D; Ruscher R; Cobos Caceres C; Jones L; Cooper M; Van Waardenberg A; Ryan S; Miles K; Field M; Dredge K; Daly NL; Giacomin PR; Loukas A
Transl Res; 2021 Jun; 232():88-102. PubMed ID: 33676036
[TBL] [Abstract][Full Text] [Related]
7. Effect of ES products from Anisakis (Nematoda: Anisakidae) on experimentally induced colitis in adult zebrafish.
Haarder S; Kania PW; Holm TL; von Gersdorff Jørgensen L; Buchmann K
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28779539
[TBL] [Abstract][Full Text] [Related]
8. Helminth secretome database (HSD): a collection of helminth excretory/secretory proteins predicted from expressed sequence tags (ESTs).
Garg G; Ranganathan S
BMC Genomics; 2012; 13 Suppl 7(Suppl 7):S8. PubMed ID: 23281827
[TBL] [Abstract][Full Text] [Related]
9. Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice.
Eichenberger RM; Ryan S; Jones L; Buitrago G; Polster R; Montes de Oca M; Zuvelek J; Giacomin PR; Dent LA; Engwerda CR; Field MA; Sotillo J; Loukas A
Front Immunol; 2018; 9():850. PubMed ID: 29760697
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease.
Sun S; Wang X; Wu X; Zhao Y; Wang F; Liu X; Song Y; Wu Z; Liu M
Parasit Vectors; 2011 Sep; 4():186. PubMed ID: 21943110
[TBL] [Abstract][Full Text] [Related]
11. Potential of human helminth therapy for resolution of inflammatory bowel disease: The future ahead.
Arai T; Lopes F
Exp Parasitol; 2022 Jan; 232():108189. PubMed ID: 34848244
[TBL] [Abstract][Full Text] [Related]
12. Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease.
Doonan J; Thomas D; Wong MH; Ramage HJ; Al-Riyami L; Lumb FE; Bell KS; Fairlie-Clarke KJ; Suckling CJ; Michelsen KS; Jiang HR; Cooke A; Harnett MM; Harnett W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30336585
[TBL] [Abstract][Full Text] [Related]
13. In silico secretome analysis approach for next generation sequencing transcriptomic data.
Garg G; Ranganathan S
BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S14. PubMed ID: 22369360
[TBL] [Abstract][Full Text] [Related]
14. Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities.
Ryan SM; Eichenberger RM; Ruscher R; Giacomin PR; Loukas A
PLoS Pathog; 2020 May; 16(5):e1008508. PubMed ID: 32407385
[TBL] [Abstract][Full Text] [Related]
15. Secretory products of helminth parasites as immunomodulators.
Harnett W
Mol Biochem Parasitol; 2014 Jul; 195(2):130-6. PubMed ID: 24704440
[TBL] [Abstract][Full Text] [Related]
16. Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics.
Harnett W; Harnett MM
Clin Exp Pharmacol Physiol; 2006; 33(5-6):511-8. PubMed ID: 16700887
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Intestinal Inflammation on Nematode's Excretory-Secretory Proteome.
Maruszewska-Cheruiyot M; Szewczak L; Krawczak-Wójcik K; Kierasińska M; Stear M; Donskow-Łysoniewska K
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762428
[TBL] [Abstract][Full Text] [Related]
18. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease.
Heylen M; Ruyssers NE; Gielis EM; Vanhomwegen E; Pelckmans PA; Moreels TG; De Man JG; De Winter BY
Pharmacol Ther; 2014 Aug; 143(2):153-67. PubMed ID: 24603369
[TBL] [Abstract][Full Text] [Related]
19. Helminth Lessons in Inflammatory Bowel Diseases (IBD).
Atagozli T; Elliott DE; Ince MN
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189818
[TBL] [Abstract][Full Text] [Related]
20. Worms and the treatment of inflammatory bowel disease: are molecules the answer?
Ruyssers NE; De Winter BY; De Man JG; Loukas A; Herman AG; Pelckmans PA; Moreels TG
Clin Dev Immunol; 2008; 2008():567314. PubMed ID: 18509490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
